| 000 -LEADER |
| fixed length control field |
05257cam a22004697i 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20260727151748.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
| fixed length control field |
cr cnu---unuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
260709s2025 nju o 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781119852285 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781119852476 |
| Qualifying information |
electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
1119852471 |
| Qualifying information |
electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781119852445 |
| Qualifying information |
electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
1119852447 |
| Qualifying information |
electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781119852469 |
| Qualifying information |
electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
1119852463 |
| Qualifying information |
electronic book |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| Cancelled/invalid ISBN |
9781119852285 |
| Qualifying information |
hardcover |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| Cancelled/invalid ISBN |
1119852285 |
| Qualifying information |
hardcover |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(OCoLC)1482532592 |
| 035 #9 - SYSTEM CONTROL NUMBER |
| System control number |
(OCLCCM-Owned)1482532592 |
| 041 ## - LANGUAGE CODE |
| Language code of text/sound track or separate title |
eng |
| 049 ## - LOCAL HOLDINGS (OCLC) |
| Holding library |
MAIN |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
| Classification number |
RS199.5 |
| Item number |
.N68 2025 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Edition number |
23 |
| Classification number |
615.6 |
| 245 00 - TITLE STATEMENT |
| Title |
Novel drug delivery systems : |
| Remainder of title |
fundamentals and applications / |
| Statement of responsibility, etc |
edited by Mehrdad Hamidi and Mahsa Sayed Tabatabaei. |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
| Place of publication, distribution, etc |
Hoboken, NJ : |
| Name of publisher, distributor, etc |
John WIley & Sons, Inc. ; |
| Place of publication, distribution, etc |
Beverly, MA : |
| Name of publisher, distributor, etc |
Scrivener Publishing LLC, |
| Date of publication, distribution, etc |
[2025] |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
1 online resource |
| 336 ## - CONTENT TYPE |
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 505 8# - CONTENTS |
| Formatted contents note |
Cover -- Series Page -- Title Page -- Copyright Page -- Contents -- Preface -- Chapter 1 Introduction to Novel Drug Delivery Systems -- 1.1 Historical Background -- 1.2 Definition, Terminology, and Taxonomy -- 1.3 Novel Drug Delivery Systems: Why, How, and What to Deliver? -- 1.3.1 Why Delivery? -- 1.3.1.1 Liberation -- 1.3.1.2 Absorption -- 1.3.1.3 Distribution -- 1.3.1.4 Metabolism -- 1.3.1.5 Excretion -- 1.3.2 How to Deliver? -- 1.3.2.1 Drug Delivery Barriers -- 1.3.2.2 Overcoming Strategies -- 1.3.2.3 Designing Criteria of NDDSs -- 1.3.3 What to Deliver? -- 1.3.3.1 Small Molecules -- 1.3.3.2 Biopharmaceuticals -- References -- Chapter 2 Novel Drug Delivery Systems: Approach to the Market -- 2.1 Introduction -- 2.2 Novel Drug Delivery Systems Global Market -- 2.2.1 Macroeconomic Indicators Affecting the Market Growth -- 2.2.2 Novel Drug Delivery Systems -- 2.2.3 Key Market Trends |
| 520 8# - SUMMARY, ETC. |
| Summary, etc |
This book serves as a unique resource on the field of novel drug delivery systems (NDDSs), catering to both academic audiences (researchers, teachers, students) and industry professionals (pharmaceutical policymakers, managers, R&D, regulatory, business development, and marketing) involved in NDDSs. The evolving nature of diseases and the emergence of new health complications have driven a significant shift in drug therapy. Coupled with changes in human lifestyles and economic conditions, these factors have compelled the pharmaceutical industry to develop novel, efficient, and affordable drug products. The rise of promising technologies aimed at enhancing therapeutic performance further underscores the importance of novel drug delivery systems (NDDSs), making this field one of the most dynamic in pharmaceutical sciences today. This book offers a comprehensive exploration of NDDS applications, catering to both academic and industry professionals. It is designed to be both user-friendly and thorough, meeting the needs of diverse readers-from those seeking practical insights to those delving deeply into the field's various sectors. The content has been meticulously compiled, organized, and analyzed by a team of experts to ensure accuracy, relevance, and currency. The book provides up-to-date information suitable for a broad audience, reflecting the wide scope of the NDDS field. The first section covers the foundational principles of NDDS, including their scientific and therapeutic basis, as well as the epidemiological and economic trends driving their development. Subsequent sections explore market-oriented aspects, such as global trends and projections. Chapters 3 to 12 present a taxonomy of NDDS categorized by their routes of administration. The book concludes with a forward-looking report on the potential future directions of NDDS. Written in clear, concise language, the book is accessible to non-native English readers, ensuring broad usability. Original figures, created by experts with scientific and graphic design expertise, enhance the reading experience and aid in understanding complex concepts. Audience A wide variety of professional readers from universities and other research institutions to health industries (industrial pharmaceutical and related), to the relevant high-tech startups to health and pharma policymakers and managers will be among the audiences of this book. |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
| Source of description note |
Description based on online resource; title from digital title page (viewed on January 08, 2025). |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drug delivery systems. |
| Authority record control number |
http://id.loc.gov/authorities/subjects/sh88007108 |
| 655 #4 - INDEX TERM--GENRE/FORM |
| Genre/form data or focus term |
Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Hamidi, Mehrdad, |
| Relator term |
editor. |
| Real World Object URI |
https://id.oclc.org/worldcat/entity/E39PCjx7XGb7jtPCFggqbWGVwd |
| Authority record control number |
http://id.loc.gov/authorities/names/n2011050268 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Tabatabaei, Mahsa Sayed, |
| Relator term |
editor. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
| Display text |
Print version: |
| International Standard Book Number |
1119852285 |
| -- |
9781119852285 |
| Record control number |
(OCoLC)1286954631 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
| Uniform Resource Identifier |
https://onlinelibrary.wiley.com/doi/book/10.1002/9781119852476 |
| Link text |
Full text is available at Wiley Online Library. Click here to view. |
| 942 ## - ADDED ENTRY ELEMENTS |
| Source of classification or shelving scheme |
|
| Item type |
EBOOK |